Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective

被引：36
|
作者：
Becker, William C. [1 ,2 ]
Fiellin, David A. [2 ,3 ]
机构：
[1] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA
[2] Yale Sch Med, New Haven, CT 06510 USA
[3] Yale Sch Publ Hlth, New Haven, CT USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 22期
关键词：
PRESCRIPTION;
D O I：
10.1056/NEJMp1701553
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2103 / 2105
页数：3
相关论文
共 50 条
  • [1] Abuse-Deterrent Opioid Formulations
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1744 - 1745
  • [2] Abuse-deterrent Opioid Formulations
    Litman, Ronald S.
    Pagan, Olivia H.
    Cicero, Theodore J.
    [J]. ANESTHESIOLOGY, 2018, 128 (05) : 1015 - 1026
  • [3] Abuse-Deterrent Opioid Formulations
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1476): : 119 - 121
  • [4] Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective
    Gadd, Shannon
    Cox, Nicholas
    Samuelson, James
    Kenney, Amy
    Turner, Kyle
    Cochran, Gerald
    [J]. THERAPEUTIC DRUG MONITORING, 2021, 43 (01) : 35 - 41
  • [5] Abuse-Deterrent Opioid Formulations #329
    O'Neill, Ryann
    Lor, Kimberly
    Pruskowski, Jennifer
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (06) : 676 - 678
  • [6] Abuse-deterrent opioid formulations: Are they a pipe dream?
    Katz N.
    [J]. Current Rheumatology Reports, 2008, 10 (1) : 11 - 18
  • [7] The role of abuse-deterrent formulations in countering opioid misuse and abuse
    Nguyen, V.
    Raffa, R. B.
    Taylor, R.
    Pergolizzi, J. V., Jr.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) : 629 - 634
  • [8] Are abuse-deterrent opioid formulations all they are crushed up to be?
    Nelson, Lewis S.
    [J]. ADDICTION, 2019, 114 (03) : 401 - 402
  • [9] Legislative Initiatives and Review of Abuse-Deterrent Opioid Formulations
    Ng, Kimberly Erin
    Ahmed, Ebtesam
    Saad, Maha
    [J]. US PHARMACIST, 2013, 38 (10) : 21 - 26
  • [10] Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations
    Walter, Carmen
    Knothe, Claudia
    Loetsch, Joern
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (07) : 751 - 767
12345